Chinese Companies in European Patent Litigation

​
September 30, 2026

The European front in global patent disputes

This opening article examines Europe’s growing role in the global patent strategies of Chinese companies, with particular emphasis on recent UPC cases involving Chinese parties as claimants and defendants, including disputes between Chinese competitors. It is the first in a series exploring the practical implications for Chinese businesses of enforcing European patents and defending against patent claims in Europe.

Chinese companies’ rapidly growing investment in European patents is changing both their opportunities and their exposure in European patent litigation. Of the 201,974 patent applications received by the EPO in 2025, 10.9% originated from the People’s Republic of China, moving China ahead of Japan (10.5%) and into the top three countries of origin for the first time.1 This growth is expanding the pool of European rights available to Chinese businesses for enforcement, while their increasing commercial presence in Europe leaves them more exposed to competing portfolios. European patent strategy is therefore becoming an increasingly important component of the global portfolio management, licensing and litigation strategies of Chinese businesses.

Chinese companies become major players in European patent litigation

Our earlier article analysed the growing presence of Chinese parties at the UPC; some of its key findings are briefly summarised here.2 It found that many Chinese defendants operated in sectors characterised by intensive patent licensing and enforcement activity, particularly telecommunications, consumer electronics and connected devices, and identified repeated enforcement campaigns against companies including Xiaomi, Transsion, Huawei, OPPO, vivo, BYD, TCL and Hisense. Increasingly, however, Chinese companies are also substantial European patent owners with their own enforcement programmes. Our review of the UPC’s public register identified 97 infringement actions filed in 2025 involving at least one Chinese party, approximately 38% of the 253 visible actions reviewed. Eighty-four involved a Chinese defendant, twenty a Chinese claimant, and seven involved Chinese parties on both sides.2 Together, these figures reflect a broader shift: Chinese companies continue to face patent actions in Europe, but are increasingly turning to European courts to enforce their own patent portfolios.

Enforcing patent rights through the Unified Patent Court

JingAo Solar v Chint/Astronergy, UPC_CFI_425/2024, illustrates affirmative UPC enforcement by a Chinese patent owner against a Chinese competitor. The case was handled at first instance by the Munich Local Division and concerned a solar-cell patent. The Court found infringement, rejected the counterclaim for revocation and granted injunctive and ancillary relief concerning Germany, France, Italy and the Netherlands.3 The parties reached a global settlement.4 The case shows a Chinese patent owner obtaining substantive multi-country relief through a German UPC division.

The more recent Yangtze Memory Technologies’ global enforcement campaign against US-based Micron concerning NAND technology demonstrates how national and UPC proceedings can be coordinated. On 18 September 2026, the Munich Regional Court granted YMTC two first-instance injunctions based on German utility models.5 In parallel, YMTC is asserting three European patents against Micron before the UPC’s Düsseldorf Local Division, alongside proceedings in the United Kingdom, the United States and China. [5] [6] The campaign shows how a Chinese patent owner can combine fast national remedies with the prospect of broader UPC relief to create leverage in a strategically important global technology dispute.

Trade fairs, evidence gathering and procedural risk

The dispute between Chinese robot-vacuum manufacturers Ecovacs and Roborock highlights both litigation between Chinese competitors and the procedural opportunities and risks associated with European trade fairs. Their contest now comprises six UPC infringement actions, alongside litigation in Germany, China and the United States.7 In March 2026, the Court of Appeal upheld the revocation of an ex parte inspection and evidence-preservation order that Ecovacs had obtained in relation to Roborock products displayed at the IFA trade fair in Berlin. The Court emphasised the applicant’s heightened duty to disclose fully and accurately all material facts relevant to necessity and proportionality.8 The dispute illustrates the risks surrounding European product launches and trade fairs, including evidence gathering and urgent procedural measures. These opportunities and risks will be examined in a forthcoming article in this series.

Abbott v Sinocare, UPC_CFI_624/2025 and UPC_CoA_899/2025, illustrates the exposure that can arise from plans directed at European markets. On 30 March 2026, the Court of Appeal rejected Sinocare’s appeal and left in place a preliminary injunction concerning a Unitary Patent. Importantly, the Court held that manufacturing and preparing products in China for sale in UPC contracting states could create the requisite likelihood of damage within UPC territory, even if the acts causing that damage occurred outside it. The decision demonstrates how European distribution plans and market-facing partnerships can expose Chinese companies to the UPC’s reach. 9

Strategic considerations for Chinese companies operating in Europe

These cases show Chinese businesses becoming increasingly active participants in the European patent system, with their portfolios, products, subsidiaries and commercial relationships placing them on either side of fast-moving disputes. The forthcoming articles will examine the practical decisions arising before and during such disputes: when to choose the UPC rather than a German national court; how service of process in China and security for costs can shape timing and economics; how to prepare for and respond to patent disputes arising at European trade fairs; when European subsidiaries, authorised representatives, distributors or other supply-chain participants may provide a jurisdictional link or become enforcement targets; and how Chinese groups should prepare for the developing cross-border reach of European courts.

Across these topics, the central theme will be the same: increased patent ownership creates enforcement opportunities, but growing commercial integration with Europe also creates exposure. Chinese companies that align portfolio management, licensing, product launches, corporate structures and litigation readiness early will be better placed to use Europe proactively rather than respond only after an action has defined the battlefield.

Author: Sebastian Fuchs - Partner, Rechtsanwalt, UPC Representative
‍

The Latest Thought Leadership pieces in the Content Hub

AI and Bitstreams at the Core of China’s Patent Update
May 28, 2025
On April 30, 2025, the China National Intellectual Property Administration (CNIPA) released a draft amendment of the Patent Examination Guidelines (for public comment), proposing further revisions to...
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
What are the options if you want to be able to use the UPC?
03 November 2022
All unitary patents fall within the competence of the Unified Patent Court (UPC). Additionally, classical validations of European Patents in states which have ratified the UPC agreement are within...
#
Patenting
​
What is the Unified Patent Court?
01 November 2022
The Unified Patent Court ("UPC") is a new pan-European court which opened for business on 1 June 2023. It adjudicates disputes relating to the new Unitary Patents and also to existing and future...
#
Litigation
​
What is the Unitary Patent and how do I get one?
01 November 2022
The Unitary Patent (UP) is a single patent right, obtained via the European Patent Office, covering all EU Member States which have ratified the agreement at the patent grant date, and is subject to...
#
Patenting
​
How does the opt-out work?
01 November 2022
The Unified Patent Court (UPC) will ultimately be responsible for all litigation in participating member states relating to patents granted by the European Patent Office (EPO); national courts in...
#
Patenting
​
What languages does the UPC use?
01 November 2022
Central Division Proceedings at the central division are in the language in which the patent was granted (i.e., either French, German or English).
#
Patenting
​
IP considerations arising from increased micro mobility competition
24 June 2022
Following the Queen's Speech, and years of consultations and lobbying from the micro mobility sector, it looks like the e-scooter industry is in for a bumper year.
#
Patenting
​
Are open-source patent portfolios the key to the EV revolution?
16 June 2022
The widespread rollout of electric vehicles is viewed as a crucial part of the UK's green revolution. When discussing how this can be achieved, charging infrastructure is often cited as the key to...
#
Patenting
​
What is the likely timing of the UPC and UP coming into being?
09 June 2022
The Unified Patent Court (UPC) is currently completing preparations to be open for business (under the Protocol on the Provisional Application of the UPC Agreement (the ‘PAP-Protocol')).
#
Litigation
​
The Unitary Patent System is on the way
20 January 2022
We reported last year that the Unitary Patent and Unified Patent Court (UPC) were progressing. The main hurdle left to clear was sufficient countries ratifying the Protocol on the Provisional...
#
Litigation
​
Hybrid event: Healthcare Innovation & Strategy Series - IP Strategy Beyond Drafting Patents
19 October 2021
We would like to invite you to join us for the second part of our life science and medtech event on 09 November where we will continue to explore upcoming trends in IP and healthcare.
#
Patenting
​
Unlocking healthcare with AI
16 September 2021
Much has been written about the development of artificial intelligence (AI) and its potential to reshape everyday life.This potential is already being realised in healthcare, with health...
#
Patenting
​
License to heal
07 September 2021
The hallmark of 5G is extremely low latency speeds. In theory, robotics could be controlled from long distances with just 0.1 seconds of a delay.
#
Patenting
​
Ask the Experts: What can I do if someone is using my invention without my permission?
02 September 2021
In the previous articles, we looked at the mechanics of filing a patent application. In this last article of our ‘Ask the Experts' series, we will be addressing some of the other ways in which a...
#
Patenting
​
The personalised healthcare boom
01 September 2021
Personalised healthcare is a fairly new term relating to technology that gives individuals effective healthcare based on their own unique attributes.
#
Patenting
​
Ask the Experts: How can I manage the costs of a patent?
24 August 2021
In previous articles, we addressed the questions of whether applying for a patent is appropriate, and if so, when this should be done. This article addresses questions around the process for filing a...
#
Patenting
​